nach oben

Erschienen in:

01.06.2014

Angiotensin II-Derived Reactive Oxygen Species Promote Angiogenesis in Human Late Endothelial Progenitor Cells Through Heme Oxygenase-1 via ERK1/2 and AKT/PI3K Pathways

verfasst von: Jingting Mai, Qiong Qiu, Yong Qing Lin, Nian Sang Luo, Hai Feng Zhang, Zhu Zhi Wen, Jing Feng Wang, Chen YangXin

Erschienen in: Inflammation | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Angiotensin II (Ang II), the main component of renin-angiotensin system, could mediate pathogenic angiogenesis in cardiovascular disorders. Late endothelial progenitor cells (EPCs) possess potent self-renewal and angiogenic potency superior to early EPCs, but few study focused on the cross-talk between Ang II and late EPCs. We observed that Ang II could increase reactive oxygen species (ROS) and promote capillary formation in late EPCs. Ang II-derived ROS could also upregulate heme oxygenase-1 (HO-1) expression, and treating late EPCs with HO-1 small interfering RNA or heme oxygenase inhibitor (HO inhibitor) could inhibit Ang II-induced tube formation and increase ROS level and apoptosis rate. In addition, PD98059 and LY294002 pretreatment attenuated Ang II-induced HO-1 expression. Accordingly, Ang II-derived ROS could promote angiogenesis in late EPCs by inducing HO-1 expression via ERK1/2 and AKT/PI3K pathways, and we believe HO-1 might be a promising intervention target in EPCs due to its potent proangiogenic, antioxidant, and antiapoptosis potentials.

Nur mit Berechtigung zugänglich

Ferrario, C.M., and W.B. Strawn. 2006. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. American Journal of Cardiology 98: 121–128.PubMedCrossRef

Nicholls, M.G., A.M. Richards, and M. Agarwal. 1998. The importance of the renin-angiotensin system in cardiovascular disease. Journal of Human Hypertension 12: 295–299.PubMedCrossRef

Egami, K., T. Murohara, T. Shimada, K. Sasaki, S. Shintani, T. Sugaya, M. Ishii, T. Akagi, H. Ikeda, T. Matsuishi, and T. Imaizumi. 2003. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. Journal of Clinical Investigation 112: 67–75.PubMedCentralPubMedCrossRef

Suganuma, T., K. Ino, K. Shibata, H. Kajiyama, T. Nagasaka, S. Mizutani, and F. Kikkawa. 2005. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clinical Cancer Research 11: 2686–2694.PubMedCrossRef

Heffelfinger, S.C. 2007. The renin angiotensin system in the regulation of angiogenesis. Current Pharmaceutical Design 13: 1215–1229.PubMedCrossRef

Otani, A., H. Takagi, H. Oh, S. Koyama, and Y. Honda. 2001. Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes 50: 867–875.PubMedCrossRef

Sasaki, K., T. Murohara, H. Ikeda, T. Sugaya, T. Shimada, S. Shintani, and T. Imaizumi. 2002. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. Journal of Clinical Investigation 109: 603–611.PubMedCentralPubMedCrossRef

De Giusti, V.C., C.D. Garciarena, and E.A. Aiello. 2009. Role of reactive oxygen species (ROS) in angiotensin II-induced stimulation of the cardiac Na+/HCO3- cotransport. Journal of Molecular and Cellular Cardiology 47: 716–722.PubMedCrossRef

Touyz, R.M. 2004. Reactive oxygen species and angiotensin II signaling in vascular cells—implications in cardiovascular disease. Brazilian Journal of Medical and Biological Research 37: 1263–1273.PubMedCrossRef

10.

Feliers, D., Y. Gorin, G. Ghosh-Choudhury, H.E. Abboud, and B.S. Kasinath. 2006. Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. American Journal of Physiology. Renal Physiology 290: F927–F936.PubMedCrossRef

11.

Uemura, H., H. Ishiguro, Y. Ishiguro, K. Hoshino, S. Takahashi, and Y. Kubota. 2008. Angiotensin II induces oxidative stress in prostate cancer. Molecular Cancer Research 6: 250–258.PubMedCrossRef

12.

Pelliccia, F., C. Cianfrocca, G. Rosano, G. Mercuro, G. Speciale, and V. Pasceri. 2010. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study. JACC. Cardiovascular Interventions 3: 78–86.PubMedCrossRef

13.

Hirschi, K.K., D.A. Ingram, and M.C. Yoder. 2008. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology 28: 1584–1595.PubMedCrossRef

14.

Ribatti, D. 2004. The involvement of endothelial progenitor cells in tumor angiogenesis. Journal of Cellular and Molecular Medicine 8: 294–300.PubMedCrossRef

15.

Gao, D., D.J. Nolan, A.S. Mellick, K. Bambino, K. McDonnell, and V. Mittal. 2008. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195–198.PubMedCrossRef

16.

Rehman, J., J. Li, C.M. Orschell, and K.L. March. 2003. Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164–1169.PubMedCrossRef

17.

Hur, J., C.H. Yoon, H.S. Kim, J.H. Choi, H.J. Kang, K.K. Hwang, B.H. Oh, M.M. Lee, and Y.B. Park. 2004. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 24: 288–293.PubMedCrossRef

18.

Endtmann, C., T. Ebrahimian, T. Czech, O. Arfa, U. Laufs, M. Fritz, K. Wassmann, N. Werner, V. Petoumenos, G. Nickenig, and S. Wassmann. 2011. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration. Hypertension 58: 394–403.PubMedCrossRef

19.

Imanishi, T., T. Hano, and I. Nishio. 2004. Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertension Research 27: 101–108.PubMedCrossRef

20.

Sanada, F., Y. Taniyama, J. Azuma, K. Iekushi, N. Dosaka, T. Yokoi, N. Koibuchi, H. Kusunoki, Y. Aizawa, and R. Morishita. 2009. Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence. Hypertension 53: 77–82.PubMedCrossRef

21.

Roks, A.J., and I.I. Angiotensin. 2011. Deteriorates endothelial progenitor cells: good intentions with bad consequences. Hypertension 58: 356–358.PubMedCrossRef

22.

Yin, T., X. Ma, L. Zhao, K. Cheng, and H. Wang. 2008. Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells. Cell Research 18: 792–799.PubMedCrossRef

23.

Aizawa, T., N. Ishizaka, J. Taguchi, R. Nagai, I. Mori, S.S. Tang, J.R. Ingelfinger, and M. Ohno. 2000. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 35: 800–806.PubMedCrossRef

24.

Dulak, J., J. Deshane, A. Jozkowicz, and A. Agarwal. 2008. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117: 231–241.PubMedCrossRef

25.

Sunamura, M., D.G. Duda, M.H. Ghattas, L. Lozonschi, F. Motoi, J. Yamauchi, S. Matsuno, S. Shibahara, and N.G. Abraham. 2003. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 6: 15–24.PubMedCrossRef

26.

Deshane, J., S. Chen, S. Caballero, A. Grochot-Przeczek, H. Was, C.S. Li, R. Lach, T.D. Hock, B. Chen, N. Hill-Kapturczak, G.P. Siegal, J. Dulak, A. Jozkowicz, M.B. Grant, and A. Agarwal. 2007. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. Journal of Experimental Medicine 204: 605–618.PubMedCentralPubMedCrossRef

27.

Berberat, P.O., Z. Dambrauskas, A. Gulbinas, T. Giese, N. Giese, B. Kunzli, F. Autschbach, S. Meuer, M.W. Buchler, and H. Friess. 2005. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clinical Cancer Research 11: 3790–3798.PubMedCrossRef

28.

Hanna, I.R., Y. Taniyama, K. Szocs, P. Rocic, and K.K. Griendling. 2002. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxidants and Redox Signaling 4: 899–914.PubMedCrossRef

29.

Imanishi, T., T. Hano, and I. Nishio. 2005. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. Journal of Hypertension 23: 97–104.PubMedCrossRef

30.

Dandapat, A., C. Hu, L. Sun, and J.L. Mehta. 2007. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 2435–2442.PubMedCrossRef

31.

Ushio-Fukai, M. 2006. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovascular Research 71: 226–235.PubMedCrossRef

32.

Circu, M.L., and T.Y. Aw. 2010. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Biology and Medicine 48: 749–762.PubMedCentralPubMedCrossRef

33.

Wu, B.J., R.G. Midwinter, C. Cassano, K. Beck, Y. Wang, D. Changsiri, J.R. Gamble, and R. Stocker. 2009. Heme oxygenase-1 increases endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology 29: 1537–1542.PubMedCrossRef

34.

Lin, H.H., Y.H. Chen, S.F. Yet, and L.Y. Chau. 2009. After vascular injury, heme oxygenase-1/carbon monoxide enhances re-endothelialization via promoting mobilization of circulating endothelial progenitor cells. Journal of Thrombosis and Haemostasis 7: 1401–1408.PubMedCrossRef

35.

Hur, J., C.H. Yoon, C.S. Lee, T.Y. Kim, I.Y. Oh, K.W. Park, J.H. Kim, H.S. Lee, H.J. Kang, I.H. Chae, B.H. Oh, Y.B. Park, and H.S. Kim. 2007. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells 25: 1769–1778.PubMedCrossRef

36.

Friedrich, E.B., C. Werner, K. Walenta, M. Bohm, and B. Scheller. 2009. Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease. Basic Research in Cardiology 104: 613–620.PubMedCrossRef

37.

Wang, J.Y., Y.T. Lee, P.F. Chang, and L.Y. Chau. 2009. Hemin promotes proliferation and differentiation of endothelial progenitor cells via activation of AKT and ERK. Journal of Cellular Physiology 219: 617–625.PubMedCrossRef

38.

Khurana, R., M. Simons, J.F. Martin, and I.C. Zachary. 2005. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112: 1813–1824.PubMedCrossRef

39.

Virmani, R., F.D. Kolodgie, A.P. Burke, A.V. Finn, H.K. Gold, T.N. Tulenko, S.P. Wrenn, and J. Narula. 2005. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arteriosclerosis, Thrombosis, and Vascular Biology 25: 2054–2061.PubMedCrossRef

Titel: Angiotensin II-Derived Reactive Oxygen Species Promote Angiogenesis in Human Late Endothelial Progenitor Cells Through Heme Oxygenase-1 via ERK1/2 and AKT/PI3K Pathways
verfasst von: Jingting Mai
Qiong Qiu
Yong Qing Lin
Nian Sang Luo
Hai Feng Zhang
Zhu Zhi Wen
Jing Feng Wang
Chen YangXin
Publikationsdatum: 01.06.2014
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 3/2014
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-013-9806-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Angiotensin II-Derived Reactive Oxygen Species Promote Angiogenesis in Human Late Endothelial Progenitor Cells Through Heme Oxygenase-1 via ERK1/2 and AKT/PI3K Pathways

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Anti-inflammatory and Antiapoptotic Effect of Interleukine-18 Binding Protein on the Spinal Cord Ischemia-Reperfusion Injury

Transcutaneous Electrical Nerve Stimulation (TENS) Accelerates Cutaneous Wound Healing and Inhibits Pro-inflammatory Cytokines

The Antioxidant Effects of Isorhamnetin Contribute to Inhibit COX-2 Expression in Response to Inflammation: A Potential Role of HO-1

Peri-Infarct Zone Characterized by Cardiac Magnetic Resonance Imaging is Directly Associated with the Inflammatory Activity During Acute Phase Myocardial Infarction

Myeloid-Derived Suppressor Cells Protect Mouse Models from Autoimmune Arthritis via Controlling Inflammatory Response

Significant Roles Played by IL-10 in Chlamydia Infections

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin